1 Raltegravir Market Overview 1.1 Product Overview and Scope of Raltegravir 1.2 Raltegravir Segment by Type 1.2.1 Global Raltegravir Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Tablet 1.2.3 Oral Powder 1.3 Raltegravir Segment by Application 1.3.1 Global Raltegravir Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Drug Store 1.3.4 Others 1.4 Global Raltegravir Market Size Estimates and Forecasts 1.4.1 Global Raltegravir Revenue 2016-2027 1.4.2 Global Raltegravir Sales 2016-2027 1.4.3 Raltegravir Market Size by Region: 2016 Versus 2021 Versus 2027 2 Raltegravir Market Competition by Manufacturers 2.1 Global Raltegravir Sales Market Share by Manufacturers (2016-2021) 2.2 Global Raltegravir Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Raltegravir Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Raltegravir Manufacturing Sites, Area Served, Product Type 2.5 Raltegravir Market Competitive Situation and Trends 2.5.1 Raltegravir Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Raltegravir Players Market Share by Revenue 2.5.3 Global Raltegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Raltegravir Retrospective Market Scenario by Region 3.1 Global Raltegravir Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Raltegravir Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Raltegravir Market Facts & Figures by Country 3.3.1 North America Raltegravir Sales by Country 3.3.2 North America Raltegravir Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Raltegravir Market Facts & Figures by Country 3.4.1 Europe Raltegravir Sales by Country 3.4.2 Europe Raltegravir Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Raltegravir Market Facts & Figures by Region 3.5.1 Asia Pacific Raltegravir Sales by Region 3.5.2 Asia Pacific Raltegravir Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Raltegravir Market Facts & Figures by Country 3.6.1 Latin America Raltegravir Sales by Country 3.6.2 Latin America Raltegravir Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Raltegravir Market Facts & Figures by Country 3.7.1 Middle East and Africa Raltegravir Sales by Country 3.7.2 Middle East and Africa Raltegravir Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Raltegravir Historic Market Analysis by Type 4.1 Global Raltegravir Sales Market Share by Type (2016-2021) 4.2 Global Raltegravir Revenue Market Share by Type (2016-2021) 4.3 Global Raltegravir Price by Type (2016-2021) 5 Global Raltegravir Historic Market Analysis by Application 5.1 Global Raltegravir Sales Market Share by Application (2016-2021) 5.2 Global Raltegravir Revenue Market Share by Application (2016-2021) 5.3 Global Raltegravir Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck & Co. 6.1.1 Merck & Co. Corporation Information 6.1.2 Merck & Co. Description and Business Overview 6.1.3 Merck & Co. Raltegravir Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck & Co. Raltegravir Product Portfolio 6.1.5 Merck & Co. Recent Developments/Updates 6.2 Hetero 6.2.1 Hetero Corporation Information 6.2.2 Hetero Description and Business Overview 6.2.3 Hetero Raltegravir Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Hetero Raltegravir Product Portfolio 6.2.5 Hetero Recent Developments/Updates 7 Raltegravir Manufacturing Cost Analysis 7.1 Raltegravir Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Raltegravir 7.4 Raltegravir Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Raltegravir Distributors List 8.3 Raltegravir Customers 9 Raltegravir Market Dynamics 9.1 Raltegravir Industry Trends 9.2 Raltegravir Growth Drivers 9.3 Raltegravir Market Challenges 9.4 Raltegravir Market Restraints 10 Global Market Forecast 10.1 Raltegravir Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Raltegravir by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Raltegravir by Type (2022-2027) 10.2 Raltegravir Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Raltegravir by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Raltegravir by Application (2022-2027) 10.3 Raltegravir Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Raltegravir by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Raltegravir by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Raltegravir Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Raltegravir Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Raltegravir Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Raltegravir Covered in This Study Table 5. Global Raltegravir Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Raltegravir Sales Market Share by Manufacturers (2016-2021) Table 7. Global Raltegravir Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Raltegravir Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Raltegravir Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Raltegravir Manufacturing Sites and Area Served Table 11. Manufacturers Raltegravir Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Raltegravir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raltegravir as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Raltegravir Sales by Region (2016-2021) & (K Units) Table 16. Global Raltegravir Sales Market Share by Region (2016-2021) Table 17. Global Raltegravir Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Raltegravir Sales by Country (2016-2021) & (K Units) Table 19. North America Raltegravir Sales Market Share by Country (2016-2021) Table 20. North America Raltegravir Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Raltegravir Revenue Market Share by Country (2016-2021) Table 22. Europe Raltegravir Sales by Country (2016-2021) & (K Units) Table 23. Europe Raltegravir Sales Market Share by Country (2016-2021) Table 24. Europe Raltegravir Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Raltegravir Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Raltegravir Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Raltegravir Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Raltegravir Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Raltegravir Revenue Market Share by Region (2016-2021) Table 30. Latin America Raltegravir Sales by Country (2016-2021) & (K Units) Table 31. Latin America Raltegravir Sales Market Share by Country (2016-2021) Table 32. Latin America Raltegravir Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Raltegravir Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Raltegravir Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Raltegravir Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Raltegravir Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Raltegravir Revenue Market Share by Country (2016-2021) Table 38. Global Raltegravir Sales (K Units) by Type (2016-2021) Table 39. Global Raltegravir Sales Market Share by Type (2016-2021) Table 40. Global Raltegravir Revenue (Million US$) by Type (2016-2021) Table 41. Global Raltegravir Revenue Share by Type (2016-2021) Table 42. Global Raltegravir Price (USD/Unit) by Type (2016-2021) Table 43. Global Raltegravir Sales (K Units) by Application (2016-2021) Table 44. Global Raltegravir Sales Market Share by Application (2016-2021) Table 45. Global Raltegravir Revenue (Million US$) by Application (2016-2021) Table 46. Global Raltegravir Revenue Share by Application (2016-2021) Table 47. Global Raltegravir Price (USD/Unit) by Application (2016-2021) Table 48. Merck & Co. Corporation Information Table 49. Merck & Co. Description and Business Overview Table 50. Merck & Co. Raltegravir Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck & Co. Raltegravir Product Table 52. Merck & Co. Recent Developments/Updates Table 53. Hetero Corporation Information Table 54. Hetero Description and Business Overview Table 55. Hetero Raltegravir Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Hetero Raltegravir Product Table 57. Hetero Recent Developments/Updates Table 58. Production Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Raltegravir Distributors List Table 61. Raltegravir Customers List Table 62. Raltegravir Market Trends Table 63. Raltegravir Growth Drivers Table 64. Raltegravir Market Challenges Table 65. Raltegravir Market Restraints Table 66. Global Raltegravir Sales Forecast by Type (2022-2027) & (K Units) Table 67. Global Raltegravir Sales Market Share Forecast by Type (2022-2027) Table 68. Global Raltegravir Revenue Forecast by Type (2022-2027) & (US$ Million) Table 69. Global Raltegravir Revenue Market Share Forecast by Type (2022-2027) Table 70. Global Raltegravir Sales Forecast by Application (2022-2027) & (K Units) Table 71. Global Raltegravir Sales Market Share Forecast by Application (2022-2027) Table 72. Global Raltegravir Revenue Forecast by Application (2022-2027) & (US$ Million) Table 73. Global Raltegravir Revenue Market Share Forecast by Application (2022-2027) Table 74. Global Raltegravir Sales Forecast by Region (2022-2027) & (K Units) Table 75. Global Raltegravir Sales Market Share Forecast by Region (2022-2027) Table 76. Global Raltegravir Revenue Forecast by Region (2022-2027) & (US$ Million) Table 77. Global Raltegravir Revenue Market Share Forecast by Region (2022-2027) Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Raltegravir Figure 2. Global Raltegravir Market Share by Type in 2020 & 2027 Figure 3. Tablet Product Picture Figure 4. Oral Powder Product Picture Figure 5. Global Raltegravir Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Drug Store Figure 8. Others Figure 9. Global Raltegravir Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Raltegravir Market Size 2016-2027 (US$ Million) Figure 11. Global Raltegravir Sales 2016-2027 (K Units) Figure 12. Global Raltegravir Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Raltegravir Sales Share by Manufacturers in 2020 Figure 14. Global Raltegravir Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Raltegravir Players: Market Share by Revenue in 2020 Figure 16. Raltegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Raltegravir Sales Market Share by Region (2016-2021) Figure 18. Global Raltegravir Sales Market Share by Region in 2020 Figure 19. Global Raltegravir Revenue Market Share by Region (2016-2021) Figure 20. Global Raltegravir Revenue Market Share by Region in 2020 Figure 21. U.S. Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Raltegravir Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Raltegravir by Type (2016-2021) Figure 46. Sales Market Share of Raltegravir by Application (2016-2021) Figure 47. Sales Market Share of Raltegravir by Application in 2020 Figure 48. Revenue Share of Raltegravir by Application (2016-2021) Figure 49. Revenue Share of Raltegravir by Application in 2020 Figure 50. Manufacturing Cost Structure of Raltegravir Figure 51. Manufacturing Process Analysis of Raltegravir Figure 52. Raltegravir Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Merck & Co. Hetero